Camelia M. Saffarini

Camelia M. Saffarini is an accomplished toxicologist with extensive experience in the pharmaceutical and research sectors. Currently serving as Associate Director of Toxicology at Alnylam Pharmaceuticals since March 2017, Camelia has advanced from Principal Scientist to Senior Scientist within the organization. Prior roles include Senior Scientist and Scientist in Research and Development at Semma Therapeutics and a postdoctoral fellowship at Massachusetts General Hospital, focusing on genetic aspects of reproductive diseases. Camelia completed postdoctoral research at Brown University, where projects included investigating gene pathways in prostate cancer. With a PhD in Pathobiology from Brown University and a BS in Toxicology from Northeastern University, Camelia has a strong foundation in both research and education. Additional early career experience includes an internship at Menzie-Cura & Associates, Inc. and a role as a Criminal Investigator Trainee at the U.S. Department of Veteran Affairs.